Skip to main content
Clinical Trials/NCT02858349
NCT02858349CompletedNot Applicable

Mechanisms of Walking Recovery After Stroke

University of Cincinnati1 site in 1 country10 target enrollmentStarted: July 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
10
Locations
1
Primary Endpoint
Walking Speed

Study Overview

Brief Summary

Subjects with stroke will have behavioral testing and brain imaging before and after a 4-week control period and a 4-week exercise intervention.

Detailed Description

Subjects with stroke will have behavioral testing and brain imaging before and after a 4-week control period and a 4-week exercise intervention using high-intensity interval training.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
Single (Outcomes Assessor)

Masking Description

Outcomes Assessor was blinded to study design, including when participant was in control phase versus intervention phase

Eligibility Criteria

Ages
30 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •age 30-90 years
  • •unilateral stroke experienced >6 months prior to enrollment in middle cerebral artery (MCA) territory without complete disruption of the putamen on the lesion side
  • •walking speed <= 1.0 m/s on the 10 meter walk test
  • •able to walk 10m over ground with assistive devices as needed and no physical assistance

Exclusion Criteria

  • •MRI incompatibility (e.g. metallic or electronic implants, severe claustrophobia)
  • •inability to perform mental imagery (time dependent motor imagery screening test [TDMI])
  • •evidence of significant arrhythmia or myocardial ischemia on treadmill ECG stress test, or significant baseline ECG abnormalities that would make an exercise ECG uninterpretable
  • •recent (<3 months) cardiopulmonary hospitalization
  • •unable to communicate with investigators or correctly answer consent comprehension questions
  • •significant ataxia or neglect (score of 2 on NIH stroke scale item 7 or 11)
  • •severe lower extremity (LE) spasticity (Ashworth >2)
  • •recent (<3 months) illicit drug or alcohol abuse or significant mental illness
  • •major post-stroke depression (PHQ-9 ≥10) in the absence of medical management
  • •participating in physical therapy or another interventional research study;
  • •recent (<3 months) paretic LE botulinum toxin injection
  • •concurrent progressive neurologic disorder or other major medical, orthopedic or peripheral vascular conditions that would limit improvement
  • •pregnancy

Arms & Interventions

Arm 1

Experimental

4-week control period with no intervention and 4-weeks of high-intensity interval training

Intervention: High-intensity interval training (Behavioral)

Arm 1

Experimental

4-week control period with no intervention and 4-weeks of high-intensity interval training

Intervention: No intervention (Behavioral)

Outcomes

Primary Outcomes

Walking Speed

Time Frame: Change from 4-weeks to 8-weeks

10-meter walk test

Secondary Outcomes

  • Aerobic Capacity(baseline, 4 weeks, 8 weeks)
  • Brain Locomotor Network Connectivity(baseline, 4 weeks, 8 weeks)
  • Stroke and Aphasia Quality of Life Scale(baseline, 4 weeks, 8 weeks)
  • Walking Capacity(baseline, 4 weeks, 8 weeks)
  • NIH Toolbox - Cognition Domain(baseline, 4 weeks, 8 weeks)
  • Metabolic Cost of Gait(baseline, 4 weeks, 8 weeks)
  • Gait Symmetry(baseline, 4 weeks, 8 weeks)
  • NIH Toolbox Standing Balance Test(baseline, 4 weeks, 8 weeks)
  • Brain Locomotor Network Activation(baseline, 4 weeks, 8 weeks)
  • Daily Walking Activity(baseline, 4 weeks, 8 weeks)
  • Walking Speed(baseline, 4 weeks, 8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pierce Boyne

Assistant Professor

University of Cincinnati

Study Sites (1)

Loading locations...

Similar Trials